These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 23202949)
21. Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients. Manna I; Iaccino E; Dattilo V; Barone S; Vecchio E; Mimmi S; Filippelli E; Demonte G; Polidoro S; Granata A; Scannapieco S; Quinto I; Valentino P; Quattrone A FASEB J; 2018 Aug; 32(8):4241-4246. PubMed ID: 29505299 [TBL] [Abstract][Full Text] [Related]
22. Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity. Regev K; Healy BC; Khalid F; Paul A; Chu R; Tauhid S; Tummala S; Diaz-Cruz C; Raheja R; Mazzola MA; von Glehn F; Kivisakk P; Dupuy SL; Kim G; Chitnis T; Weiner HL; Gandhi R; Bakshi R JAMA Neurol; 2017 Mar; 74(3):275-285. PubMed ID: 28114622 [TBL] [Abstract][Full Text] [Related]
23. The role of microRNAs involved in the disorder of blood-brain barrier in the pathogenesis of multiple sclerosis. Emami Nejad A; Mostafavi Zadeh SM; Nickho H; Sadoogh Abbasian A; Forouzan A; Ahmadlou M; Nedaeinia R; Shaverdi S; Manian M Front Immunol; 2023; 14():1281567. PubMed ID: 38193092 [TBL] [Abstract][Full Text] [Related]
24. The blood-brain barrier in multiple sclerosis: microRNAs as key regulators. Kamphuis WW; Derada Troletti C; Reijerkerk A; Romero IA; de Vries HE CNS Neurol Disord Drug Targets; 2015; 14(2):157-67. PubMed ID: 25613507 [TBL] [Abstract][Full Text] [Related]
26. miRNAs Participate in MS Pathological Processes and Its Therapeutic Response. Wu T; Chen G Mediators Inflamm; 2016; 2016():4578230. PubMed ID: 27073296 [TBL] [Abstract][Full Text] [Related]
27. Expression Profile of Selected MicroRNAs in the Peripheral Blood of Multiple Sclerosis Patients: a Multivariate Statistical Analysis with ROC Curve to Find New Biomarkers for Fingolimod. Eftekharian MM; Komaki A; Mazdeh M; Arsang-Jang S; Taheri M; Ghafouri-Fard S J Mol Neurosci; 2019 May; 68(1):153-161. PubMed ID: 30895441 [TBL] [Abstract][Full Text] [Related]
28. MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis. Thamilarasan M; Koczan D; Hecker M; Paap B; Zettl UK Autoimmun Rev; 2012 Jan; 11(3):174-9. PubMed ID: 21621006 [TBL] [Abstract][Full Text] [Related]
29. MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiology. Teuber-Hanselmann S; Meinl E; Junker A J Pathol; 2020 Apr; 250(5):496-509. PubMed ID: 32073139 [TBL] [Abstract][Full Text] [Related]
30. MiR-126: a novel route for natalizumab action? Meira M; Sievers C; Hoffmann F; Derfuss T; Kuhle J; Kappos L; Lindberg RL Mult Scler; 2014 Sep; 20(10):1363-70. PubMed ID: 24598267 [TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr Virus and miRNAs: Partners in Crime in the Pathogenesis of Multiple Sclerosis? Hassani A; Khan G Front Immunol; 2019; 10():695. PubMed ID: 31001286 [TBL] [Abstract][Full Text] [Related]
32. Genetic association and altered gene expression of mir-155 in multiple sclerosis patients. Paraboschi EM; Soldà G; Gemmati D; Orioli E; Zeri G; Benedetti MD; Salviati A; Barizzone N; Leone M; Duga S; Asselta R Int J Mol Sci; 2011; 12(12):8695-712. PubMed ID: 22272099 [TBL] [Abstract][Full Text] [Related]
34. miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis. Naghavian R; Ghaedi K; Kiani-Esfahani A; Ganjalikhani-Hakemi M; Etemadifar M; Nasr-Esfahani MH PLoS One; 2015; 10(5):e0124555. PubMed ID: 25938517 [TBL] [Abstract][Full Text] [Related]